Atorvastatin as Adjunct for Drug-Susceptible Pulmonary Tuberculosis: a Multicentre, Randomised, Open-Label Phase IIC Trial

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Adewole Olanisun Olufemi, Bolanle A. Omotoso, Olayemi Awopeju, Abbass Aminu, E. Jiya, Oluwagbemiga Oluwole Ayoola, Alexander Agada Akor, Modupe Arinola Ogunsina, Toafeek Oloyede, Taiwo Oloyede, Raliyatu Habibu, Olumide M. Sogaolu
+8 more V. Andero, Tewogbade Adeoye Adedeji, I Wasagu, Aisha Shuaibu, M. Kasumu, Abiona Odeyemi, Anthony Olubunmi Akintomide, Gregory Efosa Erhabor
DOI: 10.2139/ssrn.6143346
Cited by: 0

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Infectious Diseases and Tuberculosis Antibiotics Pharmacokinetics and Efficacy

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Language
EN
Document type
Preprint